ResearcherMarche Polytechnic UniversityActive in the last 2 years

Marco Vivarelli

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8982-2163; OpenAlex author ID A5029645660. Sources: OpenAlex.

Their work

Papers: 4
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers

Papers 4

Pancreatic cancer surgery in Italy: an updated snapshot from a national multicentre analysis of outcomes by hospital volume. Co-author DOI 10.1007/s13304-026-02813-5 ↗
Multicenter IGoMIPS Registry-based analysis of robotic versus laparoscopic approach to left pancreatectomy for pancreatic cancer. Co-author DOI 10.1007/s13304-026-02831-3 ↗
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer. Co-author DOI 10.1016/j.surg.2023.01.016 ↗
Neoadjuvant Treatment in Resectable Pancreatic Cancer. Is It Time for Pushing on It? Co-author DOI 10.3389/fonc.2022.914203 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Andrea Benedetti Cacciaguerra · 1 shared paper, 2022 · strength 0.16
- Paper Neoadjuvant Treatment in Resectable Pancreatic Cancer. Is It Time for Pushing on It? DOI 10.3389/fonc.2022.914203 ↗
Enrico Dalla Bona · 1 shared paper, 2022 · strength 0.16
- Paper Neoadjuvant Treatment in Resectable Pancreatic Cancer. Is It Time for Pushing on It? DOI 10.3389/fonc.2022.914203 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.